Evidence map›Paper›PMID 34691457›Full record

ArticleClinical case reports2021

Case series: Reinfection of recovered SARS CoV-2 patients for the third time.

Sepideh Hasanzadeh, Somayeh Sadat Shariatmaghani, Atefeh Vakilian, Alireza Javan, Mahsa Rahmani, Sara Ganjloo, Mahbubeh Jangi, Saeid Amel Jamehdar

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sepideh HasanzadehAntimicrobial Resistance Research Centre Mashhad University of Medical Sciences Mashhad Iran.
Somayeh Sadat ShariatmaghaniDepartment of Internal Medicine School of Medicine Mashhad University of Medical Sciences Mashhad Iran.
Atefeh VakilianDepartment of Infectious Diseases School of Medicine Mashhad University of Medical Sciences Mashhad Iran.
Alireza JavanDepartment of Infectious Diseases School of Medicine Mashhad University of Medical Sciences Mashhad Iran.
Mahsa RahmaniDepartment of Microbiology and virology School of Medicine Mashhad University of Medical Sciences Mashhad Iran.
Sara GanjlooFaculty of Veterinary Medicine Ferdowsi University of Mashhad Mashhad Iran.
Mahbubeh JangiDepartment of Microbiology and virology School of Medicine Mashhad University of Medical Sciences Mashhad Iran.
Saeid Amel JamehdarAntimicrobial Resistance Research Centre Mashhad University of Medical Sciences Mashhad Iran.ORCID https://orcid.org/0000-0003-4813-6399

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This set of cases provides important evidence of re-infection and recurrence of SARS-CoV-2 even for the third time. Consequently, this possibility should be considered more in recurrent patients with Covid-19 symptoms.

Indexed as

clinical case seriesreinfectionSARS‐CoV‐2

Identifiers

PMID34691457
PMCPMC8517579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.